{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:22:51Z","timestamp":1791872571360,"version":"4.3.4"},"reference-count":42,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,6]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>The prevalence of substandard and falsified (SF) antimicrobial drugs is increasing around the globe. This poses a great concern for the healthcare system. The consumption of SF antimicrobial drugs has the potential to result in treatment failure, emergence and development of antimicrobial resistance, and ultimately a rise in mortality rate. The objective of this study was to assess the quality of four commonly used antimicrobials marketed in the cities of Dire Dawa and Jijiga and the town of Togo-Wuchale, which have high potential for illegal drug trade activities in Ethiopia because they are located near the border with Somalia. A total of 54 brands\/samples of amoxicillin, amoxicillin\/clavulanic acid, ciprofloxacin, and norfloxacin formulations were collected covertly from 43 facilities using a convenience sampling strategy from March 16 to March 29, 2022. The samples were first screened using Global Pharma Health Fund (GPHF)-Minilab protocols and then analyzed using U.S. Pharmacopoeial and British Pharmacopoeia official methods. The quality evaluation detected no falsified product; however, it showed that 14.3% of the samples failed the GPHF-Minilab screening test semiquantitatively. Overall, 22.2% of the products analyzed did not meet any of pharmacopoeial specifications assessed: 13%, 12.2%, and 11.1% of the products failed in assay, dissolution, and weight variation, respectively. Additionally, 56.3% of amoxicillin samples, 60% of amoxicillin\/clavulanate, 20% of ciprofloxacin, and 54.5% of norfloxacin samples were found to be pharmaceutically nonequivalent with their respective comparator products regarding dissolution profiles. The study showed the presence of substandard antimicrobial medicines in the eastern Ethiopian market.<\/jats:p>","DOI":"10.4269\/ajtmh.23-0536","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T20:51:31Z","timestamp":1707857491000},"page":"596-608","source":"Crossref","is-referenced-by-count":4,"title":["Quality Assessment of Selected Essential Antimicrobial Drugs from Drug Retail Outlets of Selected Cities in Eastern Ethiopia"],"prefix":"10.4269","volume":"110","author":[{"given":"Hailu","family":"Anjulo","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;"},{"name":"Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worku","family":"Birhane","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Health Science, Debremarkos University, Debremarkos, Ethiopia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariaya","family":"Hymete","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayenew","family":"Ashenef","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;"},{"name":"Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Lancet Publishing Group Lancet.","first-page":"403","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017"},{"key":"b2","series-title":"Health Policy Plan","first-page":"iii1","article-title":"Access to medicines through health systems in low- and middle-income countries","volume":"34","author":"Ozawa","year":"2019"},{"key":"b3","series-title":"The Lancet","first-page":"1813","article-title":"Measuring the health-related sustainable development goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015","volume":"388","year":"2016"},{"key":"b4","series-title":"WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products","year":"2017"},{"key":"b5","series-title":"Infect Drug Resist","first-page":"3903","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019"},{"key":"b6","series-title":"S Afr Med J","first-page":"325","article-title":"The World Health Organization Global Action Plan for antimicrobial resistance","volume":"105","author":"Mendelson","year":"2015"},{"key":"b7","series-title":"BMJ Glob Health","first-page":"e008587","article-title":"Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?","volume":"7","author":"Zabala","year":"2022"},{"key":"b8","series-title":"A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products","year":"2017"},{"key":"b9","series-title":"JAMA Netw Open","first-page":"e181662","article-title":"Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries","volume":"1","author":"Ozawa","year":"2018"},{"key":"b10","year":"2019"},{"key":"b11","series-title":"Clin Microbiol Rev","first-page":"443","article-title":"Substandard\/counterfeit antimicrobial drugs","volume":"28","author":"Kelesidis","year":"2015"},{"key":"b12","series-title":"Am J Trop Med Hyg","first-page":"894","article-title":"Substandard and falsified antibiotics and medicines against noncommunicable diseases in western Cameroon and northeastern Democratic Republic of Congo","volume":"103","author":"Sch\u00e4fermann","year":"2020"},{"key":"b13","series-title":"Bull World Health Organ","first-page":"749","article-title":"Outbreak of acute renal failure in Panama in 2006: a case\u2013control study","volume":"86","author":"Rentz","year":"2008"},{"key":"b14","year":"2019"},{"key":"b15","series-title":"Am J Trop Med Hyg","first-page":"68","article-title":"Monitoring the quality of medicines: results from Africa, Asia, and South America","volume":"92","author":"Hajjou","year":"2015"},{"key":"b16","series-title":"Global Health","first-page":"1","article-title":"Substandard and falsified medical products: bibliometric analysis and mapping of scientific research","volume":"17","author":"Sweileh","year":"2021"},{"key":"b17","series-title":"Guidelines on the Conduct of Surveys of the Quality of Medicines","year":"2015"},{"key":"b18","series-title":"Ethiopian Essential Medicines List","year":"2020"},{"key":"b19","series-title":"PLoS One","first-page":"e0251400","article-title":"Trends of community-based systemic antibiotic consumption: comparative analyses of data from Ethiopia and Norway calls for public health policy actions","volume":"16","author":"Gutema","year":"2021"},{"key":"b20","series-title":"J Antimicrob Chemother","first-page":"214","article-title":"Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence","volume":"60","author":"Kelesidis","year":"2007"},{"key":"b21","series-title":"GPHF-Minilab: A Concise Quality Control Guide on Essential Drugs and other Medicines Manual","year":"2020"},{"key":"b22","year":"2021"},{"key":"b23","series-title":"The British Pharmacopoeia","year":"2021"},{"key":"b24","article-title":"","year":"1997"},{"key":"b25","series-title":"AAPS J","first-page":"263","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010"},{"key":"b26","series-title":"Pharmaceutical Dosage Forms and Drugs Delivery System","author":"Allen","year":"2009"},{"key":"b27","series-title":"Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry","year":"2015"},{"key":"b28","series-title":"Pharmaceutics","first-page":"1703","article-title":"A critical overview of FDA and EMA statistical methods to compare in\u00a0vitro drug dissolution profiles of pharmaceutical products","volume":"13","author":"Musel\u00edk","year":"2021"},{"key":"b29","series-title":"AAPS PharmSciTech","first-page":"201","article-title":"Modeling of in\u00a0vitro dissolution profiles of carvedilol immediate-release tablets in different dissolution media","volume":"23","author":"Usta","year":"2022"},{"key":"b30","year":"2015"},{"key":"b31","series-title":"Rev Panam Salud Publica","article-title":"Substandard, falsified and unregistered medicines in Latin America, 2017\u20132018","volume":"44","author":"Rojas-Cort\u00e9s","year":"2020"},{"key":"b32","series-title":"Eur J Clin Pharmacol","first-page":"1029","article-title":"It is time to review how unlicensed medicines are used","volume":"71","author":"Sutherland","year":"2015"},{"key":"b33","series-title":"Ethiopian Pharm J","first-page":"1","article-title":"Comparative in\u00a0vitro quality evaluation of ciprofloxacin tablets from drug retail outlets in Addis Ababa, Ethiopia","volume":"25","author":"Kahsay","year":"2007"},{"key":"b34","series-title":"Dissolut Technol","first-page":"1","article-title":"In vitro comparative dissolution assessment of different brands of co-amoxiclav tablets in Pakistan","volume":"27","author":"Waqas","year":"2020"},{"key":"b35","year":"2011"},{"key":"b36","series-title":"Afr Health Sci","first-page":"369","article-title":"Evaluation and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules","volume":"13","author":"Kassaye","year":"2013"},{"key":"b37","series-title":"Int J Pharm Sci Nanotechnol","first-page":"1966","article-title":"Comparative in\u00a0vitro bioequivalence evaluation of different brands of amoxicillin capsules marketed in Tigray, Ethiopia","volume":"6","author":"Hailu","year":"2013"},{"key":"b38","series-title":"Pharmaceutics","first-page":"18","article-title":"Quality attributes and in\u00a0vitro bioequivalence of different brands of amoxicillin trihydrate tablets","volume":"9","author":"Al-Tabakha","year":"2017"},{"key":"b39","series-title":"Drug Des Devel Ther","first-page":"1241","article-title":"In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia","volume":"13","author":"Hambisa","year":"2019"},{"key":"b40","series-title":"Int J Res Pharm Sci","first-page":"33","article-title":"Comparative in-vitro bioequivalence analysis of some brands of ciprofloxacin HCl tablets marketed in Ethiopia","volume":"8","author":"Hintsa","year":"2018"},{"key":"b41","series-title":"Die Pharmazie Int J Pharm Sci","first-page":"483","article-title":"Pharmaceutical product development technologies based on the biopharmaceutical classification system","volume":"64","author":"Jain","year":"2009"},{"key":"b42","series-title":"Pharmaceutical Dissolution Testing, Bioavailability, and Bioequivalence","author":"Banakar","year":"2022"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/110\/3\/article-p596.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/110\/3\/article-p596.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/110\/3\/article-p596.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T13:55:58Z","timestamp":1709733358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/110\/3\/article-p596.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":42,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.23-0536","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}